The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
117087582 11708758 2 F 20100406 20160822 20151107 20160822 EXP FR-BRISTOL-MYERS SQUIBB COMPANY-15323637 BRISTOL MYERS SQUIBB 0.00 DY F Y 1.69000 KG 20160822 OT FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
117087582 11708758 1 PS ATAZANAVIR SULFATE ATAZANAVIR SULFATE 1 Transplacental UNK U 21567
117087582 11708758 2 SS SUSTIVA EFAVIRENZ 1 Transplacental UNK U 0 CAPSULE
117087582 11708758 3 C ZIAGEN ABACAVIR SULFATE 1 Transplacental UNK U 0
117087582 11708758 4 C NORVIR RITONAVIR 1 Transplacental UNK U 0
117087582 11708758 5 C VIREAD TENOFOVIR DISOPROXIL FUMARATE 1 Transplacental UNK U 0
117087582 11708758 6 C RETROVIR ZIDOVUDINE 1 Transplacental UNK U 0
117087582 11708758 7 C MICARDIS PLUS HYDROCHLOROTHIAZIDETELMISARTAN 1 Transplacental U 0
117087582 11708758 8 C SPASFON PHLOROGLUCINOL 1 Transplacental U 0
117087582 11708758 9 C CELESTENE BETAMETHASONE 1 Transplacental U 0
117087582 11708758 10 C CLAMOXYL AMOXICILLINCLAVULANIC ACID 1 Transplacental U 0
117087582 11708758 11 C LOXEN NICARDIPINE HYDROCHLORIDE 1 Transplacental U 0
117087582 11708758 12 C VITAMIN D CHOLECALCIFEROL 1 Transplacental U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
117087582 11708758 1 Product used for unknown indication
117087582 11708758 2 Product used for unknown indication
117087582 11708758 3 Product used for unknown indication
117087582 11708758 4 Product used for unknown indication
117087582 11708758 5 Product used for unknown indication
117087582 11708758 6 Product used for unknown indication
117087582 11708758 7 Product used for unknown indication
117087582 11708758 8 Product used for unknown indication
117087582 11708758 9 Product used for unknown indication
117087582 11708758 10 Product used for unknown indication
117087582 11708758 11 Product used for unknown indication
117087582 11708758 12 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
117087582 11708758 CA
117087582 11708758 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
117087582 11708758 Cardiomegaly
117087582 11708758 Congenital pulmonary valve atresia
117087582 11708758 Congenital tricuspid valve atresia
117087582 11708758 Foetal exposure during pregnancy
117087582 11708758 Neonatal respiratory distress syndrome
117087582 11708758 Premature baby
117087582 11708758 Ventricular hypoplasia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
117087582 11708758 1 20091119 20100406 0
117087582 11708758 2 20091001 0
117087582 11708758 3 20100406 0
117087582 11708758 4 20100406 0
117087582 11708758 5 20100406 0
117087582 11708758 6 20100406 20100406 0